Checkpoint Therapeutics PE Ratio 2016-2021 | CKPT

Current and historical p/e ratio for Checkpoint Therapeutics (CKPT) from 2016 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Checkpoint Therapeutics PE ratio as of September 23, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Checkpoint Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-09-23 3.53 0.00
2021-06-30 2.95 $-0.47 0.00
2021-03-31 3.14 $-0.44 0.00
2020-12-31 2.65 $-0.41 0.00
2020-09-30 2.68 $-0.46 0.00
2020-06-30 1.98 $-0.52 0.00
2020-03-31 1.51 $-0.58 0.00
2019-12-31 1.72 $-0.70 0.00
2019-09-30 2.49 $-0.86 0.00
2019-06-30 3.03 $-1.03 0.00
2019-03-31 2.86 $-1.11 0.00
2018-12-31 1.82 $-1.28 0.00
2018-09-30 3.58 $-1.16 0.00
2018-06-30 2.98 $-1.10 0.00
2018-03-31 4.39 $-1.15 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.284B $0.001B
Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New York City.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71